Butyrate Selectively Targets Super‐Enhancers and Transcriptional Networks Associated with Human Mast Cell Function
European Journal of Immunology · 2025-06 · 55 (6)
DOI: 10.1002/eji.202451680 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Immunology, online erschienen am 11.06.2025. Verfasst von Jelle Folkerts und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary Medicine, Erasmus MC, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands. Hauptthemen laut MEDLINE: Mast Cells, Butyrates, Gene Regulatory Networks, Enhancer Elements, Genetic. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dutch Research Council Vidi, Dutch Lung Foundation Junior Investigator, Lung Foundation Netherlands.
Abstract (Originalsprache)
Mast cells are key drivers of allergic inflammation. We have previously shown that butyrate, a short‐chain fatty acid derived from dietary fibers, inhibits human mast cell activation and degranulation. Here, we characterized the mechanisms underlying butyrate‐mediated control of mast cell activity. To this end, we assessed the genome‐wide impact of butyrate, a histone deacetylase (HDAC) inhibitor, on the epigenomic control of mast cell gene expression by integrating transcriptome and histone acetylation (H3K27Ac) profiles obtained from butyrate‐treated primary human mast cells. Butyrate affected a selective set of genes and gene regulatory elements in mast cells. Most prominent was the hypoacetylation of promoter regions of highly expressed genes and super‐enhancers controlling key mast cell identity genes. Perturbation of super‐enhancer activity via pharmacological bromodomain inhibition suppressed degranulation of primary human mast cells, evoking repression of key mast cell identity genes that resembled the inhibitory effects of butyrate. Our data indicate that butyrate inhibits human mast cell activity via surprisingly selective targeting of super‐enhancers to regulate the core mast cell transcriptional program.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pulmonary Medicine, Erasmus MC, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.
- Department of Pathology, Stanford University School of Medicine, Stanford, California, USA.
- Center for Biomics, Erasmus MC, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.
ORCID-Profile: Wilfred F J van IJcken, Ralph Stadhouders
Förderung
- Dutch Research Council Vidi
- Dutch Lung Foundation Junior Investigator
- Lung Foundation Netherlands
Zitieren
APA
Folkerts, J., de Bruijn, M. J. W., van IJcken, W. F. J., Hendriks, R. W., & Stadhouders, R. (2025). Butyrate Selectively Targets Super‐Enhancers and Transcriptional Networks Associated with Human Mast Cell Function. European Journal of Immunology, 55(6). https://doi.org/10.1002/eji.202451680
Vancouver
Folkerts J, de Bruijn MJW, van IJcken WFJ, Hendriks RW, Stadhouders R. Butyrate Selectively Targets Super‐Enhancers and Transcriptional Networks Associated with Human Mast Cell Function. European Journal of Immunology. 2025;55(6). doi:10.1002/eji.202451680
BibTeX
@article{Folkerts2025,
author = {Folkerts, Jelle and de Bruijn, Marjolein J W and van IJcken, Wilfred F J and Hendriks, Rudi W and Stadhouders, Ralph},
title = {Butyrate Selectively Targets Super‐Enhancers and Transcriptional Networks Associated with Human Mast Cell Function},
journal = {European Journal of Immunology},
year = {2025},
volume = {55},
number = {6},
doi = {10.1002/eji.202451680}
}
EUVIMED